Comments
AstraZeneca starts new study of heart drug versus rival
18.07.2012. | LONDON (Reuters) - AstraZeneca is to conduct a new global clinical trial of key new heart drug Brilinta involving 11,500 patients with peripheral artery disease, Britain's second biggest drugmaker said on Tuesday....
